Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-01
2005-03-01
Trinh, Ba K. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S337000, C514S449000, C514S471000, C546S281700, C549S060000, C549S473000, C549S510000, C549S511000
Reexamination Certificate
active
06861446
ABSTRACT:
Taxanes having a heterosubstituted acetate substituent at C(7), a hydroxy substituent at C(10), and a range of C(2), C(9), C(14), and side chain substituents.
REFERENCES:
patent: 4960790 (1990-10-01), Stella et al.
patent: 5175315 (1992-12-01), Holton
patent: 5243045 (1993-09-01), Holton et al.
patent: 5277400 (1994-01-01), Holten et al.
patent: 5283253 (1994-02-01), Holton et al.
patent: 5350866 (1994-09-01), Holton et al.
patent: 5430160 (1995-07-01), Holton
patent: 5567614 (1996-10-01), Patel et al.
patent: 5614645 (1997-03-01), Kingston et al.
patent: 5714513 (1998-02-01), Holton et al.
patent: 5721268 (1998-02-01), Holton et al.
patent: 5767297 (1998-06-01), Mandai et al.
patent: 5780653 (1998-07-01), Tao et al.
patent: 5811452 (1998-09-01), Ojima et al.
patent: 5879929 (1999-03-01), Patel
patent: 5912264 (1999-06-01), Wittman et al.
patent: 5939561 (1999-08-01), Bourzat et al.
patent: 6136988 (2000-10-01), Murray et al.
patent: 0 534 709 (1993-03-01), None
patent: 0 558 959 (1993-09-01), None
patent: 0 629 701 (1994-12-01), None
patent: 0 882 732 (1998-12-01), None
patent: 212 577 (1993-02-01), None
patent: 09-241293 (1997-09-01), None
patent: WO 9318018 (1993-09-01), None
patent: WO 9613495 (1996-05-01), None
patent: WO 9709979 (1997-03-01), None
patent: WO 9742181 (1997-11-01), None
patent: WO 9909021 (1999-02-01), None
patent: WO 0157013 (2001-08-01), None
Gueritte-Voegelein et al. “Relationships between the Structure of Taxol Analogues and Their Antimitotic Activity” Journal of Medicinal Chemistry, vol. 34, No. 3 (1991) pp. 992-998.
Kant et al. “A Chemoselective Approach to Functionalize the C-10 Position of 10-Deacetylbaccatin III. Synthesis and Biological Properties of Novel C-10 Taxol Analogues” Tetrahedron Letters, vol. 35, No. 30 (1994) pp. 5543-5546.
Kingston et al. “The Chemistry of Taxol, A Clinically Useful Anticancer Agent” Journal of Natural Products, vol. 53, No. 1 (1990) pp. 1-12.
Mellado et al. “Preparation and Biological Activity of Taxol Acetates” Biochemical and Biophysical Research Communications, vol. 124, No. 2 (1984) pp. 329-336.
Samaranayake et al. “Modified Taxols. 5. Reaction of Taxol with Electrophilic Reagents and Preparation of a Rearranged Taxol Derivative with Tubulin Assembly Activity” J. Org. Chem., vol. 56, No. 17 (1991) pp. 5114-5119.
Straubinger et al. “Pharmacology and Antitumor Effect of Novel Placlitaxel Formulations” Chapter 8, Edited by G. Georg et al., Taxane Anticancer Agents, Basic Science and Current Status, ACS Symposium Series 583, 207th National Meeting of the American Chemical Society, San Diego, CA (1994) pp. 111-123.
Suffness “Chapter 32. Taxol: From Discovery to Therapeutic Use” Annual Reports in Medicinal Chemistry, vol. 28 (1993) pp. 305-314.
Hungarian Patent Office, Novelty Search Report for Application No. P02 00651, dated Aug. 29, 2002.
International Search Report from analogues PCT application No. PCT/US01/03600 dated Jun. 7, 2001.
FSU Research Foundation, Inc.
Senniger Powers
Trinh Ba K.
LandOfFree
C7 heterosubstituted acetate taxane compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with C7 heterosubstituted acetate taxane compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C7 heterosubstituted acetate taxane compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3419145